Similar to Harding disease in LHON, OPA1 mutation carriers can also develop an MS-like illness where the optic atrophy occurs on the background of a more disseminated inflammatory process with neuroradiological and serological features, consistent with MS [133, 147]. This evidence concerns the gene OPA1 and optic atrophy.